Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemiaPARK, Mi-Jung; PARK, Soon-Ho; JUNSHIK HONG et al.International journal of hematology. 2013, Vol 98, Num 5, pp 549-557, issn 0925-5710, 9 p.Article

Tracing origin of serrated adenomas with BRAF and KRAS mutationsEUI JIN LEE; CHOI, Chan; CHEOL KEUN PARK et al.Virchows Archiv. 2005, Vol 447, Num 3, pp 597-602, issn 0945-6317, 6 p.Article

Controversies in Antiepidermal Growth Factor Receptor Therapy in Metastatic Colorectal CancerWOO, Janghee; PALMISIANO, Neil; TESTER, William et al.Cancer. 2013, Vol 119, Num 11, pp 1941-1950, issn 0008-543X, 10 p.Article

Genetic Polymorphisms of FcγRlla and FcγRllla Are Not Predictive of Clinical Outcomes after Cetuximab plus Irinotecan Chemotherapy in Patients with Metastatic Colorectal CancerSEONG JOON PARK; YONG SANG HONG; JIN CHEON KIM et al.Oncology. 2012, Vol 82, Num 2, pp 83-89, issn 0030-2414, 7 p.Article

BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancerTANAKA, Hirofumi; GUOREN DENG; MATSUZAKI, Koji et al.International journal of cancer. 2006, Vol 118, Num 11, pp 2765-2771, issn 0020-7136, 7 p.Article

MEK inhibition in non-small cell lung cancerSTINCHCOMBE, Thomas E; JOHNSON, Gary L.Lung cancer. 2014, Vol 86, Num 2, pp 121-125, issn 0169-5002, 5 p.Article

Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancerBOZZETTI, Cecilia; NALDI, Nadia; DE FILIPPO, Massimo et al.Lung cancer. 2013, Vol 80, Num 1, pp 35-38, issn 0169-5002, 4 p.Article

KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomasALEXANDER, Riley E; LOPEZ-BELTRAN, Antonio; MEEHAN, Kari et al.Histopathology. 2012, Vol 61, Num 6, pp 1036-1042, issn 0309-0167, 7 p.Article

KRAS Genotyping as Biomarker in Colorectal Cancer: A Comparison of Three Commercial Kits on Histologic MaterialCAVALLINI, Aldo; VALENTINI, Anna Maria; LIPPOLIS, Catia et al.Anticancer research. 2010, Vol 30, Num 12, pp 5251-5256, issn 0250-7005, 6 p.Article

Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancerTOUGERON, David; CORTES, Ulrich; FERRU, Aurélie et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 2, pp 397-403, issn 0344-5704, 7 p.Article

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre studyGRIEKEN, N. C. T. Van; AOYMA, T; ZHANG, S. L et al.British journal of cancer. 2013, Vol 108, Num 7, pp 1495-1501, issn 0007-0920, 7 p.Article

EGFR and KRAS mutations in metastatic lung adenocarcinomasMUNFUS-MCCRAY, Delicia; HARADA, Shuko; ADAMS, Christina et al.Human pathology. 2011, Vol 42, Num 10, pp 1447-1453, issn 0046-8177, 7 p.Article

KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line TherapyKULLMANN, F; HARTMANN, A; KUTSCHEIDT, A et al.Oncology. 2011, Vol 81, Num 1, pp 3-8, issn 0030-2414, 6 p.Article

Targeting KRAS Mutation-bearing Lung Cancer In Vivo by Pulmonary Surfactant-Adenovirus-mediated Gene TransferFUKAZAWA, Takuya; MAEDA, Yutaka; DURBIN, Mary L et al.Anticancer research. 2010, Vol 30, Num 12, pp 4925-4935, issn 0250-7005, 11 p.Article

Cetuximab plus cisplatin-5-fluorouracil versus cisplatin- 5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase 11 study of the Arbeitsgemeinschaft lnternistische OnkologieLORENZEN, S; SCHUSTER, T; MÜLLER, L et al.Annals of oncology. 2009, Vol 20, Num 10, pp 1667-1673, issn 0923-7534, 7 p.Article

KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cellsNAKADATE, Yusuke; KODERA, Yasuo; KITAMURA, Yuka et al.International journal of cancer (Print). 2014, Vol 134, Num 9, pp 2146-2155, issn 0020-7136, 10 p.Article

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapyCSEREPES, Mihaly; OSTOROS, Gyula; GYULAI, Marton et al.European journal of cancer (1990). 2014, Vol 50, Num 10, pp 1819-1828, issn 0959-8049, 10 p.Article

Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 StudyKARAMPEAZIS, Athanasios; VOUTSINA, Alexandra; AGELAKI, Sofia et al.Cancer. 2013, Vol 119, Num 15, pp 2754-2764, issn 0008-543X, 11 p.Article

Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three TrialsMODEST, Dominik P; BRODOWICZ, Thomas; KIRCHNER, Thomas et al.Oncology. 2012, Vol 83, Num 5, pp 241-247, issn 0030-2414, 7 p.Article

Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosisBOUCHAHDA, Mohamed; KARABOUE, Abdoulaye; SAFFROY, Raphaël et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 3, pp 605-609, issn 0344-5704, 5 p.Article

Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancerPERKINS, Geraldine; LIEVRE, Astrid; BOUCHE, Olivier et al.International journal of cancer (Print). 2010, Vol 127, Num 6, pp 1321-1331, issn 0020-7136, 11 p.Article

KRAS Mutation Influences Recurrence Patterns in Patients Undergoing Hepatic Resection of Colorectal MetastasesKEMENY, Nancy E; CHOU, Joanne F; JINRU SHIA et al.Cancer. 2014, Vol 120, Num 24, pp 3965-3971, issn 0008-543X, 7 p.Article

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetBLONS, H; EMILE, J. F; BRIDGEWATER, J et al.Annals of oncology. 2014, Vol 25, Num 12, pp 2378-2385, issn 0923-7534, 8 p.Article

The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancerDOWLER NYGAARD, Anneli; GARM SPINDLER, Karen-Lise; PALLISGAARD, Niels et al.Lung cancer. 2013, Vol 79, Num 3, pp 312-317, issn 0169-5002, 6 p.Article

Therapeutic efficiency of everolimus and lapatinib in xenograft model of human colorectal carcinoma with KRAS mutationCHU, Céline; NOËL-HUDSON, Marie-Sophie; BOIGE, Valérie et al.Fundamental & clinical pharmacology. 2013, Vol 27, Num 4, pp 434-442, issn 0767-3981, 9 p.Article